The Cellular, Tissue and Gene Therapies Advisory Committee held a virtual public meeting meeting on 2-3rd September on the toxicity risks...

The ASGCT sponsored a roundtable event of talks by industry experts on AAV integration. These discussions were extremely interesting and...

Saqlain Suleman has joined the TestAVec team as Principal Scientific Officer. He will be working to develop and lead projects in...

Bluebird Bio has halted a phase 3 gene therapy clinical trial against cerebral adrenoleukodystrophy. This trial use lentiviral vectors...

TestaAVec will be attending the ESGCT Virtual Congress, this October. The Congress will be joint with other European gene therapy...